A novel proteosome-liposaccharide vaccine adjuvant

Details for Australian Patent Application No. 2002245636 (hide)

Owner ID Biomedical Corporation of Quebec

Inventors Jones, David; Burt, David S.; Lowell, George H.; White, Gregory L.; Rioux, Clement

Agent Griffith Hack

Pub. Number AU-B-2002245636

PCT Pub. Number WO2002/072012

Priority 60/274,232 09.03.01 US; 60/327,297 09.10.01 US

Filing date 11 March 2002

Wipo publication date 24 September 2002

Acceptance publication date 14 October 2004

International Classifications

A61K 039/02 Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 039/112 Medicinal preparations containing antigens or antibodies - Salmonella

A61K 039/108 Medicinal preparations containing antigens or antibodies - Escherichia

C07K 001/00 General processes for the preparation of peptides

C07H 001/00 Processes for the preparation of sugar derivatives

A61K 039/385 Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61K 039/116 Medicinal preparations containing antigens or antibodies - Polyvalent bacterial antigens

A61K 039/095 Medicinal preparations containing antigens or antibodies - Neisseria

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-B-2002245636

14 October 2004 Application Accepted

  Published as AU-B-2002245636

10 February 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002245637-METHOD FOR GENERATING REPLACEMENT CELLS AND/OR TISSUES

2002245635-Strip for whitening tooth surfaces